Page last updated: 2024-10-24

busulfan and Esophageal Stricture

busulfan has been researched along with Esophageal Stricture in 3 studies

Research Excerpts

ExcerptRelevanceReference
"Dyskeratosis congenita is recognized by its dermal lesions and constitutional aplastic anemia in some cases."1.30Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation. ( Alimoghadam, K; Ghahremani, G; Ghavamzadeh, A; Jahani, M; Khodabandeh, A; Nasseri, P, 1999)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stemmelin, GR1
Pest, P1
Peters, RA1
Ceresetto, JM1
Shanley, CM1
Bullorsky, EO1
Ghavamzadeh, A1
Alimoghadam, K1
Nasseri, P1
Jahani, M1
Khodabandeh, A1
Ghahremani, G1
Canales Albendea, MA1
Alvarez Román, MT1
Villanueva Pavón, R1
Hernández Navarro, F1

Other Studies

3 other studies available for busulfan and Esophageal Stricture

ArticleYear
Severe esophageal stricture after autologous bone marrow transplant.
    Bone marrow transplantation, 1995, Volume: 15, Issue:6

    Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; B

1995
Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation.
    Bone marrow transplantation, 1999, Volume: 23, Issue:3

    Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Busulfan; Chronic Disease; Cycloph

1999
[Severe esophageal stenosis secondary to the administration of chemotherapy in a patient with acute myeloblastic leukemia].
    Sangre, 1999, Volume: 44, Issue:3

    Topics: Anti-Infective Agents; Anti-Ulcer Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan;

1999